Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Inks Animal Health JV With Chinese Company Jilin Guoyuan

This article was originally published in PharmAsia News

Executive Summary

Pfizer Inc. announced a joint venture Sept. 8 with China's Jilin Guoyuan Animal Heatlh Company, Ltd. to develop, manufacture and distribute animal health vaccines in China

You may also be interested in...



Where’s The Beef? China Pushes For More Stringent Controls On Veterinary Drugs

A draft proposal by the Ministry of Agriculture comes at a time when several Big Pharma are pursuing opportunities in China’s veterinary market.

Pfizer: Established Products And Consumer Health In; Animal Health And Nutrition Out

Pfizer takes a middle-of-the-road approach to breaking out non-core businesses, announcing plans to explore alternatives for Animal Health and Nutrition.

Pfizer Divests Its Swine Vaccine Business To Harbin Pharmaceutical Group In China As Condition Of $68 Billion Merger With Wyeth

SHANGHAI - Pfizer recently completed the divestment of its swine vaccine business in China to local company Harbin Bio-Vaccine, an animal health subsidiary of Harbin Pharmaceutical Group

Related Content

UsernamePublicRestriction

Register

SC143420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel